Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck

Journal of Clinical Oncology

Volumn 17, Issue 11, 1999, Pages 3503-3511

  Colevas, A D ^a   Norris, C M ^a   Tishler, R B ^a   Fried, M P ^a   Gomolin, H I ^a   Amrein, P ^a   Nixon, A ^a   Lamb, C ^a   Costello, R ^a   Barton, J ^a   Read, R ^a   Adak, S ^a   Posner, M R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; HEAD CANCER; HUMAN; KIDNEY DISEASE; MUCOSA INFLAMMATION; NAUSEA; NECK CANCER; NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0032701094     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1999.17.11.3503     Document Type: Article

References (33)

1. Dimery I, Hong W: Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85:95-111, 1993
2. Lefebvre J, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88:890-898, 1996
3. Merlano M, Benasso M, Corvo R, et al: Five year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583-589, 1996
4. Paccagnella A, Orlando A, Marchiori C, et al: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86:265-272, 1994
5. Vokes E, Weichselbaum R, Lippman S, et al: Head and neck cancer. N Engl J Med 328:184-194, 1993
6. Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1689, 1991
7. Kish J, Ensley J, Jacobs J, et al: A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 56:2740-2744, 1985
8. Vokes E, Schilsky R, Weichselbaum R, et al: Induction chemotherapy with cisplatin, fluorouracil and high-dose leucovorin for locally advanced head and neck cancer: A clinical and pharmacologic analysis. J Clin Oncol 8:241-247, 1990
9. Schneider M, Etienne M, Milano G, et al: Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: A pharmacokinetic and clinical survey. J Clin Oncol 13:1656-1662, 1995
10. Pfister D, Bajorin D, Motzer R, et al: Cisplatin. fluorouracil, and leucovorin: Increased toxicity without improved response in squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 120:89-95, 1994
11. Papadimitrakopoulou V, Dimery I, Lee J, et al: Cisplatin, fluorouracil. and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: The M.D. Anderson Cancer Center experience. Cancer J 3:92-99, 1997
12. Clark J, Busse P, Norris C, et al: Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: Long-term results. J Clin Oncol 15:3100-3110, 1997
13. Dreyfuss A, Clark J, Wright J, et al: Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 112:167-172, 1990
14. Dreyfuss A, Clark J, Norris C, et al: Taxotere for advanced, inoperable squamous cell carcinoma of the head and neck (SCCHN). Proc Am Soc Clin Oncol 13:287, 1994 (abstr)
15. Catimel G, Verwij J, Hanauske A: Docetaxel (Taxotere): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. Ann Oncol 5:553-537, 1994
16. Couteau C, Leyvraz S, Oulid-Aissa D, et al: A phase II study of docetaxel in squamous cell carcinoma (SCC) of the head and neck. Proc Am Soc Clin Oncol 15:315, 1996 (abstr)
17. Fujii H, Sasaki Y, Ebihara S, et al: An early phase II study of docetaxel (Taxotere) in patients with head and neck cancer. Proc Am Soc Clin Oncol 14:298, 1995 (abstr 859)
18. Colevas A, Busse P, Norris C, et al: Induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil, and leucovorin (TPFL5) for squamous cell carcinoma of the head and neck: A phase I/II trial. J Clin Oncol 16:1331-1339, 1998
19. Vogel M, Hilsenbeck S, Depenbrock H, et al: Preclinical activity of Taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with Taxol and conventional antineoplastic agents. Eur J Cancer 29A:2009-2014, 1993
20. Bissery MC, Vrignaud P, Lavelle F: Preclinical profile of docetaxel (Taxotere): Efficacy as a single agent and in combination. Semin Oncol 22:3-16, 1995
21. Schellens J, Ma J, Bruno R, et al: Pharmacokinetics of cisplatin and Taxotere (docetaxel) and WBC DNA-adduct formation of cisplatin in the sequence Taxotere in a phase I/II study in solid tumor patients. Proc Am Soc Clin Oncol 13:132, 1994 (abstr)
22. Schellens J, Ma J, Planting A, et al: Docetaxel (Taxotere) inhibits DNA-adduct formation and intracellular accumulation of cisplatin in human WBC but not in tumor cell lines. Proc Am Soc Clin Oncol 35:212, 1994 (abstr)
23. Burris HA III: Docetaxel in combination with fluorouracil for advanced solid tumors. Oncology (Huntingt) 11:50-52, 1997)
24. American Joint Committee on Cancer: AJCC Cancer Staging Manual (ed 5). Philadelphia, PA, Lippincott-Raven, 1997
25. Vokes E, Weichselbaum R, Mick R, et al: Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 84:877-882, 1992
26. El-Saved S, Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials. J Clin Oncol 14:838-847, 1996
27. Munro A: An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71:83-91, 1995
28. Al-Sarraf M, LeBlanc M, Shanker Giri P, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. J Clin Oncol 16:1310-1317, 1998
29. Briel D, Albers M, Fisher S, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998
30. Abitol A, Sridhar K, Lewin A, et al: Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (± granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma. Cancer 80:266-276, 1997
31. Adelstein D, Sharan V, Earle A, et al: Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 65:1685-1691, 1990
32. Taylor S, Murthy A, Vannetzel J, et al: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12:385-395, 1994
33. Merlano M, Rosso R, Sertoli R, et al: Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: A phase III study. J Clin Oncol 6:627-632, 1988